Legal entity
Every one of those 1 sits in a single category, regulation. DOJ is most often covered alongside Catherine Hanaway, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.3 for the same window.
Last mentioned: Mar 13, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. DOJ is most often covered alongside Catherine Hanaway, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.3 for the same window. At 8, the average consequence score sits above the same-window beat average of 6.4. DOJ appears in 1 tracked Legal story from March 13, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 42 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering DOJ. Shared-story counts are live from our verified record — not editorial picks.
Missouri Stay Request
DOJ files request in Missouri court to pause litigation pending FDA review.
Legislative Action
Senator Josh Hawley introduces a Senate bill to outright ban the abortion pill.
Louisiana Request
DOJ asks Louisiana court to pause a similar lawsuit; request is largely ignored by the state.
Amended Complaint
AG Catherine Hanaway files amended complaint targeting mail-order abortion drugs.
Lawsuit Filed
Missouri, Kansas, and Idaho file suit against the FDA over mifepristone approval.
The U.S. Department of Justice has requested federal courts in Missouri to pause litigation challenging the FDA's approval of mifepristone, citing an ongoing internal agency review. This tactical shift suggests a preference for administrative rulemaking over high-profile court battles as the administration navigates the legal complexities of reproductive health regulation.
Source: Danielle Han (us) · yahoo.com
DOJ is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
